Boothbay Fund Management »

Edgewise Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $174k 11k 16.22
2025-03-31 $1.9M 85k 22.00
2022-09-30 $147k 15k 9.85

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Cormorant Asset Management
Siren
Perceptive Advisors
Bellevue Group
Driehaus Capital Management
MPM Oncology Impact Management

View all funds holding Edgewise Therapeutics